产品说明书

UVI 3003

Print
Chemical Structure| 847239-17-2 同义名 : -
CAS号 : 847239-17-2
货号 : A971133
分子式 : C28H36O4
纯度 : 98%
分子量 : 436.583
MDL号 : MFCD18086862
存储条件：

粉末 Inert atmosphere,Store in freezer, under -20°C

液体 -20°C:3-6个月-80°C:12个月
溶解度 :

DMSO: 105 mg/mL(240.5 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO
动物实验配方：
生物活性
描述 Retinoid X receptors occupy a central position in the nuclear receptor superfamily for the heterodimers formed by RXRs with many other family members are involved in the control of a variety of (patho)physiologic processes. UVI 3003 is a potent and selective RXR antagonist, used as a tool to test the contribution of RXR to transactivation by a given RXR heterodimer. UVI 3003 at concentration of 10μM could almost completely reverse depression of proliferation and increased apoptosis by combined RAR and RXR agonists in PLB985 cells in 12 days, but did not significantly affect growth inhibition or apoptosis in NB4 cells exposed to RAR agonists possibly because of the obliteration of the RXR requirement for apoptosis due to PML-RAR fusion protein. UVI 3003 can fully antagonize CD3254, a potent RXR agonist, induced transcription through Gal4-RXR in HeLa cells stably transfected with the reporter recombinant 5xGal4-βGlo-Luc and Gal4-hRXRβ.
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

2.29mL

0.46mL

0.23mL

11.45mL

2.29mL

1.15mL

22.91mL

4.58mL

2.29mL